{"disease":{"id":"er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer-with-disease-progression-following-at-least-one-line-of-endocrine-therapy.md","name":"er positive her2 negative esr1 mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}